These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12356410)

  • 1. Influence of morphine sulfate on cocaine-induced coronary vasoconstriction.
    Saland KE; Hillis LD; Lange RA; Cigarroa JE
    Am J Cardiol; 2002 Oct; 90(7):810-1. PubMed ID: 12356410
    [No Abstract]   [Full Text] [Related]  

  • 2. Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin.
    Brogan WC; Lange RA; Kim AS; Moliterno DJ; Hillis LD
    J Am Coll Cardiol; 1991 Aug; 18(2):581-6. PubMed ID: 1906905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate effects of intravenous cocaine on the thoracic aorta and coronary arteries. A transesophageal echocardiographic study.
    Eisenberg MJ; Yakel DL; Mendelson J; Redberg RF; Jones RT; Foster E
    Chest; 1996 Jul; 110(1):147-54. PubMed ID: 8681619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous cocaine causes epicardial coronary vasoconstriction in the intact dog.
    Hayes SN; Moyer TP; Morley D; Bove AA
    Am Heart J; 1991 Jun; 121(6 Pt 1):1639-48. PubMed ID: 2035378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of cocaine, ethanol, or their combination on epicardial coronary arterial dimensions in humans.
    Pirwitz MJ; Willard JE; Landau C; Lange RA; Glamann DB; Kessler DJ; Foerster EH; Todd E; Hillis LD
    Arch Intern Med; 1995 Jun; 155(11):1186-91. PubMed ID: 7763124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine-induced vasoconstriction in the human coronary microcirculation: new evidence from myocardial contrast echocardiography.
    Gurudevan SV; Nelson MD; Rader F; Tang X; Lewis J; Johannes J; Belcik JT; Elashoff RM; Lindner JR; Victor RG
    Circulation; 2013 Aug; 128(6):598-604. PubMed ID: 23812179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cocaine on the coronary arteries.
    Benzaquen BS; Cohen V; Eisenberg MJ
    Am Heart J; 2001 Sep; 142(3):402-10. PubMed ID: 11526352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute interactions of buprenorphine with intravenous cocaine and morphine: an investigational new drug phase I safety evaluation.
    Teoh SK; Mendelson JH; Mello NK; Kuehnle J; Sintavanarong P; Rhoades EM
    J Clin Psychopharmacol; 1993 Apr; 13(2):87-99. PubMed ID: 8463453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune cell activity during the initial stages of withdrawal from chronic exposure to cocaine or morphine.
    Avila AH; Alonzo NC; Bayer BM
    J Neuroimmunol; 2004 Feb; 147(1-2):109-13. PubMed ID: 14741439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cocaine on coronary artery dimensions in atherosclerotic coronary artery disease: enhanced vasoconstriction at sites of significant stenoses.
    Flores ED; Lange RA; Cigarroa RG; Hillis LD
    J Am Coll Cardiol; 1990 Jul; 16(1):74-9. PubMed ID: 2358608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near syncope associated with concomitant clozapine and cocaine use.
    Hameedi FA; Sernyak MJ; Navui SA; Kosten TR
    J Clin Psychiatry; 1996 Aug; 57(8):371-2. PubMed ID: 8752022
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of cocaine-induced vasoconstriction of left and right coronary arterial systems.
    Vongpatanasin W; Lange RA; Hillis LD
    Am J Cardiol; 1997 Feb; 79(4):492-3. PubMed ID: 9052356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade.
    Lange RA; Cigarroa RG; Flores ED; McBride W; Kim AS; Wells PJ; Bedotto JB; Danziger RS; Hillis LD
    Ann Intern Med; 1990 Jun; 112(12):897-903. PubMed ID: 1971166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent coronary vasoconstriction caused by intranasal cocaine: possible role for metabolites.
    Brogan WC; Lange RA; Glamann DB; Hillis LD
    Ann Intern Med; 1992 Apr; 116(7):556-61. PubMed ID: 1543310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alleviation of cocaine-induced coronary vasoconstriction with intravenous verapamil.
    Negus BH; Willard JE; Hillis LD; Glamann DB; Landau C; Snyder RW; Lange RA
    Am J Cardiol; 1994 Mar; 73(7):510-3. PubMed ID: 8141094
    [No Abstract]   [Full Text] [Related]  

  • 16. Cocaine-induced coronary-artery vasoconstriction.
    Lange RA; Cigarroa RG; Yancy CW; Willard JE; Popma JJ; Sills MN; McBride W; Kim AS; Hillis LD
    N Engl J Med; 1989 Dec; 321(23):1557-62. PubMed ID: 2573838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cocaine produces coronary artery vasoconstriction independent of an intact endothelium.
    Kuhn FE; Gillis RA; Virmani R; Visner MS; Schaer GL
    Chest; 1992 Aug; 102(2):581-5. PubMed ID: 1643952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic cocaine treatment enhances the responsiveness of the left anterior descending coronary artery and the femoral artery to vasoactive substances.
    Jones LF; Tackett RL
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1366-70. PubMed ID: 2262907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A laboratory model of cocaine withdrawal in humans: intravenous cocaine.
    Foltin RW; Fischman MW
    Exp Clin Psychopharmacol; 1997 Nov; 5(4):404-11. PubMed ID: 9386968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medical complications caused by cocaine consumption].
    Rello J; Net A
    Med Clin (Barc); 1987 Nov; 89(16):694-7. PubMed ID: 3320604
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.